Relative Strength Chart Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.085 USD | +2.49% |
|
-15.79% | +10.55% |
| 08/07 | Perspective Therapeutics, Inc. Announces Executive Changes | CI |
| 08/07 | Perspective Therapeutics Names Paul Lyne Chief Science Officer as Co-Founder Michael Schultz Moves to Advisory Role | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PERSPECTIVE THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.16% | -15.79% | +10.55% | -24.00% | -59.03% | 34Cr |  | | |
- Stock Market
- Stocks
- CATX Stock
- Charts Perspective Therapeutics, Inc.
- Relative Strength Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
